According to Hansoh Pharma
's latest financial reports the company has $3.24 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $3.13 B | 5.52% |
2021-12-31 | $2.97 B | 41.27% |
2020-12-31 | $2.10 B | 0.68% |
2019-12-31 | $2.08 B | 311.31% |
2018-12-31 | $0.50 B | 91.71% |
2017-12-31 | $0.26 B | 36.87% |
2016-12-31 | $0.19 B |